• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 5. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Halopyridines Polyhalopyridines

Recent Advances in the Study of 3,4-Dichloro-2-Pyridinemethanol (CAS: 103949-59-3) in Chemical Biology and Pharmaceutical Research

3,4-Dichloro-2-Pyridinemethanol (CAS: 103949-59-3) is a chemically significant pyridine derivative that has garnered increasing attention in the fields of chemical biology and pharmaceutical research. This compound, characterized by its dichloro-substituted pyridine ring and hydroxymethyl functional group, has shown promising potential in various applications, including drug synthesis, enzyme inhibition, and as a building block for more complex bioactive molecules. Recent studies have explored its pharmacological properties, synthetic pathways, and potential therapeutic applications, making it a subject of considerable scientific interest.

One of the key areas of research involving 3,4-dichloro-2-Pyridinemethanol is its role as an intermediate in the synthesis of novel pharmaceutical compounds. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the development of kinase inhibitors, which are critical for targeting cancer-related signaling pathways. The study highlighted the compound's ability to serve as a scaffold for modifications that enhance binding affinity and selectivity toward specific kinase targets. Furthermore, the dichloro substitution pattern was found to contribute significantly to the compound's stability and bioavailability, making it a valuable candidate for further drug development.

In addition to its synthetic applications, 3,4-dichloro-2-Pyridinemethanol has been investigated for its direct biological activity. Research published in Bioorganic & Medicinal Chemistry Letters in 2022 revealed that this compound exhibits moderate inhibitory effects against certain bacterial enzymes, suggesting potential applications in antimicrobial therapy. The study employed molecular docking simulations and in vitro assays to elucidate the interaction between the compound and bacterial targets, providing a foundation for future structure-activity relationship (SAR) studies. These findings underscore the versatility of 3,4-dichloro-2-Pyridinemethanol as both a synthetic intermediate and a bioactive molecule.

Another notable advancement in the study of this compound is its use in the development of agrochemicals. A recent report in Pest Management Science detailed the synthesis of derivatives of 3,4-dichloro-2-Pyridinemethanol with enhanced herbicidal activity. The researchers optimized the compound's structure to improve its efficacy against resistant weed species, demonstrating the potential for this chemical scaffold to address challenges in agricultural pest control. This application highlights the cross-disciplinary relevance of 3,4-dichloro-2-Pyridinemethanol, bridging the gap between pharmaceutical and agrochemical research.

Despite these promising developments, challenges remain in the large-scale production and optimization of 3,4-dichloro-2-Pyridinemethanol. A 2023 review in Organic Process Research & Development discussed the need for more efficient synthetic routes to reduce costs and environmental impact. The review also emphasized the importance of exploring greener catalytic methods to enhance the sustainability of its production. Addressing these challenges will be crucial for maximizing the compound's potential in both academic and industrial settings.

In conclusion, 3,4-dichloro-2-Pyridinemethanol (CAS: 103949-59-3) represents a versatile and valuable compound in chemical biology and pharmaceutical research. Its applications range from drug synthesis to antimicrobial and herbicidal activity, showcasing its broad utility. Continued research into its synthetic optimization and biological mechanisms will likely uncover further opportunities for innovation in these fields. As such, this compound remains a focal point for scientists seeking to develop novel therapeutic and agrochemical solutions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)